Which meals are included?

Breakfast, lunch as well as morning and afternoon snacks are provided at the conference, served in the exhibition hall.

Yes. Please contact the customer care team for more details at customercare@strategyinstitute.com.

Can I send a replacement delegate if I can’t attend at the last minute?

Yes. Please contact the customer care team at customercare@strategyinstitute.com at your earliest convenience.

I have special meal requirements. Who do I contact?

Please contact the customer care team at customercare@strategyinstitute.com so they can liaise with the venue to ensure you are taken care of.

When will the presentations be available, and how do I get them?

Presentations will be available once the conference has concluded, typically within a week. You will receive an email from the customer care team with the link to download the presentations. Please note that not all speakers are able to release their presentations due to confidentiality reasons.

26th Annual Market Access Summit 2027

The event has ended! Stay tune for the Next Event!

26th ANNUALMARKET ACCESS
SUMMIT

Canada’s largest and most influential event for market access, reimbursement, and government policy experts

Toronto, ON

October, 2027

WHY ATTEND REGISTER YOUR INTEREST FOR 2027

The event has ended! Stay tune for the Next Event!

20+ HOURS OF INNOVATIVE CONTENT

10+ HOURS OF NETWORKING

45+ TOP MARKET ACCESS SPEAKERS

93% OVERALL ATTENDEE SATISFACTION AT PREVIOUS EDITIONS

Unlock the Market Access 2025
Post-Event Report

Explore how Canada’s top market access leaders are shaping the future of pricing, policy, and patient access through HTA evolution, pharmacare strategy, and next-generation reimbursement models.

DOWNLOAD THE REPORT

WHERE POLICY, INNOVATION & ACCESS CONVERGED

The 25th Annual Market Access Summit brought together market access leaders, policy makers, payers, and industry innovators from across Canada’s pharmaceutical landscape for two days of candid policy updates, practical strategy, and meaningful networking. Attendees heard directly from the regulators, HTA bodies, and negotiators shaping access in Canada as pricing pressure, National Pharmacare, and AI-enabled evidence redefine the path to reimbursement.

Policy & Regulation: Charted the Road Ahead

Explored how Health Canada’s Red Tape Review and first Ministerial Reliance Order are opening new submission opportunities
Gained clarity on Canada’s Drug Agency’s progress and priorities on the road to 2030

Pricing & Reimbursement: Navigated a Shifting Landscape

Demystified pCPA negotiation dynamics, including accelerated negotiation pathways
Assessed what U.S. MFN pricing proposals mean for Canadian launch sequencing and price sustainability

Evidence & Innovation: Redefined Value

Examined how RWE and generative AI are becoming the new currencies for access
Uncovered how international real-world experience can reduce HTA uncertainty ahead of Canadian launch

The summit featured leaders from Canada’s Drug Agency, Health Canada, PMPRB, pCPA, Innovative Medicines Canada, BC Ministry of Health, Alberta Ministry of Health, AbbVie, AstraZeneca, Sanofi, Roche, Merck, Amgen, Bayer, Gilead Sciences, Green Shield Canada, Manulife, and many more.

CONNECTED WITH PEERS THROUGH INTERACTIVE SESSIONS

Attendees connected, engaged, and learned alongside Canada’s top market access experts through a range of dynamic formats designed to encourage collaboration, knowledge sharing, and meaningful networking. Highlights included:

Keynotes, panel discussions, fireside chats, and case studies featuring federal, provincial, and industry leaders.
Roundtable discussions on where AI is adding value across HTA and market access, and where it should be avoided.
Face-to-face networking opportunities, including speed networking.
Live virtual streaming that expanded access for attendees across Canada.
Networking breakfasts, lunches, and an evening drinks reception.

DROVE ACCESS, NAVIGATED POLICY & DELIVERED REAL-WORLD IMPACT

Heard the latest government guidance directly from the President & CEO of Canada’s Drug Agency on navigating the road to 2030 in a shifting global landscape.
Mastered reimbursement and pricing frameworks for public and private payers with insights from the pCPA, Health Canada, and the PMPRB.
Defined value through RWE and generative AI with Merck, Amgen, AstraZeneca, and Circulus Consulting.
Drew early lessons from National Pharmacare implementation in British Columbia and Ontario’s FAST oncology pathway.
Positioned for Phase 2 of the National Strategy for Drugs for Rare Diseases with Health Canada.

VIEW 2026 AGENDA

OUR DELEGATES INCLUDE:

WHO ATTENDED?

The summit welcomed senior executives from across Canada’s market access ecosystem, bringing together professionals responsible for reimbursement, pricing strategy, policy, patient access, and real-world evidence to share best practices and build connections that drive meaningful access for patients across Canada.

REPRESENTED SECTORS INCLUDED:

Senior Executives Attended From:

Pharmaceuticals: Market Access, Government Affairs, Health Technology Assessment (HTA) & Reimbursement, Real-World Evidence, Pharma Economics, Pricing, Patient Access Programs, Medical Affairs.
BioTech: Market Access, Government Affairs, HTA & Reimbursement, Real-World Evidence, Pharma Economics, Pricing, Patient Access Programs, Medical Affairs.
Medical Devices: Market Access & Reimbursement, Health Economics & Outcomes Research (HEOR), Value-Based Partnerships, Strategic Policy.
MedTech: Market Access & Reimbursement, Health Economics & Outcomes Research (HEOR), Value-Based Partnerships, Strategic Policy.
Provincial: Drug Programs, Health System Planning, Reimbursement & Coverage, Policy, Public Drug Plans, Health Innovation Strategy, Health Technology Assessment (HTA).
Federal: Market Access, Policy, Health Economists, Senior Policy Analysts, Regulatory Affairs, HTA, Pharmaceutical Policy & Pricing.
Private Payers: Group Benefits, Drug Benefit Solutions, Pharmacy Services, Health Benefits Strategy.
Patient Groups: Senior Management, Patient Advocacy, Access & Equity.
Healthcare: Patient Experience, Patient Relations, Patient-Centred Care Teams.
Educational Institutions: Health Policy Researchers & Health Systems Programs